Survodutide: Research Summary and How to Judge a Supplier
GLP-1 and glucagon dual agonist with published phase 2 metabolic and liver outcomes. This profile sets out what is actually published, what a 10mg vial should cost, and the specific documentation to ask for before ordering Survodutide from any research supplier.
10mg
Typical vial
$50
Lowest tracked
$71
Median price
86
Vendors listing
What Survodutide is
Survodutide is a dual glucagon and GLP-1 receptor agonist that has reported phase 2 results in obesity and in MASH, with phase 3 programmes running. Among the newer metabolic peptides it has a comparatively concrete clinical dataset behind it.
It is also complex to synthesise, and the research market for dual agonists has a documented history of vials containing a cheaper single agonist instead. Identity confirmation, not purity alone, is the check that matters.
What the evidence base looks like
The published record is early: a coherent mechanism, a handful of encouraging studies, and very little independent replication at human scale.
Our library records roughly 22 relevant publications for Survodutide and grades the evidence as emerging. That grade describes the weight of research, not a judgement about safety or effect, and it is reviewed as new work is published.
Supplier quality: what to check on Survodutide
Dual agonists are frequently substituted with cheaper semaglutide-class material, which a purity-only certificate will not reveal.
The practical checklist is the same on every product but weighted differently here: a batch-matched certificate of analysis, an identity method appropriate to this molecule rather than purity alone, clear peptide content per 10mg vial, and a supplier that will answer a technical question before taking payment.
Typical UK pricing
The lowest price we currently track for a 10mg vial is £49.90, against a market median nearer £71. Compare on price per milligram rather than per vial, because vial sizes across suppliers are rarely identical.
A listing well below the tracked low is worth investigating rather than celebrating. On this compound the cost of doing it properly is largely analytical, and that is the first thing an unusually cheap supplier stops paying for.
Frequently asked
Is Survodutide approved for human use?
No. Everything listed here is supplied for laboratory research use only, and nothing on this page is medical advice.
How much should Survodutide cost?
Tracked UK prices start around £49.90 for a 10mg vial, with the market median closer to £71.
What is the single most useful check on Survodutide?
Dual agonists are frequently substituted with cheaper semaglutide-class material, which a purity-only certificate will not reveal.
Search focus for this profile
survodutide — Tracked monthly searches, difficulty Monitored. Source: Semrush (UK database).
Supporting terms covered: survodutide review, buy survodutide uk, survodutide price, best survodutide supplier.
Everything below describes published research and market data. Nothing here is medical advice, and none of these compounds are sold or supplied by CheckALab.
More in Metabolic
Semaglutide
GLP-1 receptor agonist with a large human clinical trial record in metabolic research.
Tirzepatide
Dual GIP/GLP-1 agonist studied in large randomized metabolic endpoints.
Retatrutide
Triple agonist with phase 2 metabolic results published and phase 3 ongoing.
5-Amino-1MQ
Small-molecule NNMT inhibitor studied in adipocyte and metabolic models.
Liraglutide
First-generation GLP-1 agonist with a large clinical trial literature behind it.
Lipo-C
Lipotropic compounded solution of methionine, inositol, choline and B vitamins.
AOD9604
Growth hormone fragment 176-191 studied for lipolytic activity, with human trial data.
Mazdutide
GLP-1 and glucagon dual agonist based on oxyntomodulin, with phase 3 data in China.
MOTS-c
Mitochondrial-derived peptide studied in exercise metabolism and insulin sensitivity models.